{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:05:54Z","timestamp":1789621554320,"version":"build-2803163510"},"reference-count":293,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many measures of increased inflammation in severe COVID-19 that also accompany its autoimmune complications, including coagulopathies, myocarditis and multisystem inflammatory syndrome in children (MIS-C). This paper integrates currently disparate measures of innate hyperactivation in severe COVID-19 and its autoimmune complications, and relates these to SARS-CoV-2 activation of innate immunity. Aggregated data include activation of Toll-like receptors (TLRs), nucleotide-binding oligomerization domain (NOD) receptors, NOD leucine-rich repeat and pyrin-domain-containing receptors (NLRPs), retinoic acid-inducible gene I (RIG-I) and melanoma-differentiation-associated gene 5 (MDA-5). SARS-CoV-2 mainly activates the virus-associated innate receptors TLR3, TLR7, TLR8, NLRP3, RIG-1 and MDA-5. Severe COVID-19, however, is characterized by additional activation of TLR1, TLR2, TLR4, TLR5, TLR6, NOD1 and NOD2, which are primarily responsive to bacterial antigens. The innate activation patterns in autoimmune coagulopathies, myocarditis and Kawasaki disease, or MIS-C, mimic those of severe COVID-19 rather than SARS-CoV-2 alone suggesting that autoimmunity follows combined SARS-CoV-2-bacterial infections. Viral and bacterial receptors are known to synergize to produce the increased inflammation required to support autoimmune disease pathology. Additional studies demonstrate that anti-bacterial antibodies are also required to account for known autoantigen targets in COVID-19 autoimmune complications.<\/jats:p>","DOI":"10.3390\/ijms24033001","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T05:09:20Z","timestamp":1675400960000},"page":"3001","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3298-9306","authenticated-orcid":false,"given":"Robert","family":"Root-Bernstein","sequence":"first","affiliation":[{"name":"Department of Physiology, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R. (2020). Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134645"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R. (2021). Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI\/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042108"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.intimp.2007.05.016","article-title":"Toll-like receptors in inflammation, infection and cancer","volume":"7","author":"Chen","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2012.00328","article-title":"NOD1 and NOD2 Signaling in Infection and Inflammation","volume":"3","author":"Moreira","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/eji.201242396","article-title":"Respiratory syncytial virus infection augments NOD2 signaling in an IFN-\u03b2-dependent manner in human primary cells","volume":"42","author":"Vissers","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.4049\/jimmunol.1301412","article-title":"Nod1 and Nod2 enhance TLR-mediated invariant NKT cell activation during bacterial infection","volume":"191","author":"Selvanantham","year":"2013","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2012.06.007","article-title":"TLR8 and NOD signaling synergistically induce the production of IL-1\u03b2 and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2","volume":"218","author":"Schwarz","year":"2013","journal-title":"Immunobiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1128\/IAI.73.12.7967-7976.2005","article-title":"Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells","volume":"73","author":"Tada","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Knudsen, M.L., Johansson, D.X., Kostic, L., Nordstr\u00f6m, E.K., Tegerstedt, K., Pasetto, A., Applequist, S.E., Ljungberg, K., Sirard, J.C., and Liljestr\u00f6m, P. (2013). The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065964"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2016.07.016","article-title":"Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators","volume":"133","author":"Kamaladasa","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.4049\/jimmunol.1501819","article-title":"Intracellular RIG-I Signaling Regulates TLR4-Independent Endothelial Inflammatory Responses to Endotoxin","volume":"196","author":"Moser","year":"2016","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4049\/jimmunol.2001327","article-title":"The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression","volume":"206","author":"Huang","year":"2021","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R. (2021). Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines, 9.","DOI":"10.3390\/vaccines9050474"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2100158","DOI":"10.1002\/bies.202100158","article-title":"COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors","volume":"43","year":"2021","journal-title":"Bioessays"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"923485","DOI":"10.3389\/fpubh.2022.923485","article-title":"Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Udompornpitak, K., Bhunyakarnjanarat, T., Chindamporn, A., Tovichayathamrong, P., Torvorapanit, P., Chiewchengchol, D., Chancharoenthana, W., and Leelahavanichkul, A. (2022). Neutrophil Extracellular Traps in Severe SARS-CoV-2 Infection: A Possible Impact of LPS and (1\u21923)-\u03b2-D-glucan in Blood from Gut Translocation. Cells, 11.","DOI":"10.3390\/cells11071103"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104941","DOI":"10.1016\/j.micpath.2021.104941","article-title":"Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis","volume":"156","author":"Hoque","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_22","first-page":"2459","article-title":"Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/cid\/ciaa524","article-title":"Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?","volume":"71","author":"Clancy","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e0016321","DOI":"10.1128\/Spectrum.00163-21","article-title":"Coinfections with Other Respiratory Pathogens among Patients with COVID-19","volume":"9","author":"Sreenath","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s15010-020-01553-x","article-title":"Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia","volume":"49","author":"Elabbadi","year":"2021","journal-title":"Infection."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e155055","DOI":"10.1172\/jci.insight.155055","article-title":"Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza","volume":"7","author":"Cambier","year":"2022","journal-title":"JCI Insight"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cts.12953","article-title":"SARS-CoV-2 infection as a trigger of autoimmune response","volume":"14","author":"Sacchi","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e154886","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"934270","DOI":"10.3389\/fmed.2022.934270","article-title":"Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity","volume":"9","author":"Stjepanovic","year":"2022","journal-title":"Front. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-323-91532-8.00004-5","article-title":"Neurologic complications of coronavirus and other respiratory viral infections","volume":"189","author":"Cavallieri","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00415-020-10131-y","article-title":"COVID-19: Dealing with a potential risk factor for chronic neurological disorders","volume":"268","author":"Schirinzi","year":"2021","journal-title":"J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102898","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rojas","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"626182","DOI":"10.3389\/fped.2020.626182","article-title":"Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment","volume":"8","author":"McMurray","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11926-021-01028-4","article-title":"Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease","volume":"23","author":"Bukulmez","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"704929","DOI":"10.3389\/fped.2021.704929","article-title":"Correlation Analysis of Anti-Cardiolipin Antibody\/D Dimer\/C-Reactive Protein and Coronary Artery Lesions\/Multiple-Organ Damage in Children with Kawasaki Disease","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2147363","DOI":"10.1001\/jamanetworkopen.2021.47363","article-title":"Temporal Correlation Between Kawasaki Disease and Infectious Diseases in South Korea","volume":"5","author":"Kang","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/jmv.23950","article-title":"Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease","volume":"86","author":"Shirato","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11795565221075319","DOI":"10.1177\/11795565221075319","article-title":"A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated with COVID-19","volume":"16","author":"Shahbaz","year":"2022","journal-title":"Clin. Med. Insights Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QCO.0b013e3280964d8c","article-title":"The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease","volume":"20","author":"Matsubara","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3345\/kjp.2018.06989","article-title":"High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease","volume":"62","author":"Min","year":"2019","journal-title":"Korean J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yexmp.2003.12.003","article-title":"Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease","volume":"76","author":"Thomas","year":"2004","journal-title":"Exp. Mol. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kornitzer, J., Johnson, J., Yang, M., Pecor, K.W., Cohen, N., Jiang, C., and Ming, X. (2021). A Systematic Review of Characteristics Associated with COVID-19 in Children with Typical Presentation and with Multisystem Inflammatory Syndrome. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168269"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Overcoming COVID-19 Investigators. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"355","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lazova, S., Dimitrova, Y., Hristova, D., Tzotcheva, I., and Velikova, T. (2022). Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C-Can We Match the Puzzle?. Antibodies, 11.","DOI":"10.3390\/antib11020025"},{"key":"ref_51","unstructured":"Son, M.B.F., and Friedman, K. (2022, September 22). COVID-19: Multisystem Inflammatory Syndrome in Children (MIS-C) Clinical Features, Evaluation, and Diagnosis UpToDate, Literature Review Current through: August 2022.|This Topic Last Updated: 28 April 2022. Available online: https:\/\/www.uptodate.com\/contents\/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis#H3359371996."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2020.00295","article-title":"Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease","volume":"8","author":"Ching","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fped.2018.00210","article-title":"Incomplete Refractory Kawasaki Disease in an Infant\u2014A Case Report and a Review of the Literature","volume":"6","author":"Gozar","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13052-016-0306-z","article-title":"Kawasaki disease in Sicily: Clinical description and markers of disease severity","volume":"42","author":"Maggio","year":"2016","journal-title":"Ital. J. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kusuda, T., Nakashima, Y., Murata, K., Kanno, S., Nishio, H., Saito, M., Tanaka, T., Yamamura, K., Sakai, Y., and Takada, H. (2014). Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113054"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"948770","DOI":"10.3389\/fmicb.2022.948770","article-title":"Toll-like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/ATVBAHA.121.316210","article-title":"Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome","volume":"41","author":"Wang","year":"2021","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"P291","DOI":"10.1186\/1532-429X-17-S1-P291","article-title":"Role of C reactive protein in evaluating the extent of myocardial inflammation in acute myocarditis","volume":"17","author":"Goitein","year":"2015","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930802208540","article-title":"Antigenic complementarity between coxsackie virus and streptococcus in the induction of rheumatic heart disease and autoimmune myocarditis","volume":"42","author":"Vonck","year":"2009","journal-title":"Autoimmunity"},{"key":"ref_60","first-page":"85","article-title":"Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of Disease","volume":"2","year":"2014","journal-title":"Front. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtbi.2014.11.022","article-title":"Unresolved issues in theories of autoimmune disease using myocarditis as a framework","volume":"375","author":"Fairweather","year":"2015","journal-title":"J. Theor. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11882-013-0407-3","article-title":"Complexities in the relationship between infection and autoimmunity","volume":"14","author":"Fairweather","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s13054-020-03332-4","article-title":"Severe manifestations of SARS-CoV-2 in children and adolescents: From COVID-19 pneumonia to multisystem inflammatory syndrome: A multicentre study in pediatric intensive care units in Spain","volume":"24","author":"Vicente","year":"2020","journal-title":"Crit. Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S2352-4642(20)30215-7","article-title":"Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study","volume":"4","author":"Davies","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","article-title":"Acute Ischemic Stroke and COVID-19: An Analysis of 27676 Patients","volume":"52","author":"Qureshi","year":"2021","journal-title":"Stroke"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2020.10.075","article-title":"Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19","volume":"231","author":"Smilowitz","year":"2021","journal-title":"Am. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2020.05.006","article-title":"The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China","volume":"192","author":"Fu","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of Antiphospholipid Syndrome in the General Population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Emmenegger, M., Kumar, S.S., Emmenegger, V., Malinauskas, T., Buettner, T., Rose, L., Schierack, P., Sprinzl, M.F., Sommer, C.J., and Lackner, K.J. (2021). Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog., 17.","DOI":"10.1101\/2021.06.21.449211"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.scib.2021.07.033","article-title":"Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort","volume":"66","author":"Liu","year":"2021","journal-title":"Sci. Bull."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.41472","article-title":"Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy","volume":"73","author":"Gkrouzman","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R., Huber, J., and Ziehl, A. (2022). Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911500"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s10067-021-05580-3","article-title":"Anti-phospholipids antibodies and immune complexes in COVID-19 patients: A putative role in disease course for anti-annexin-V antibodies","volume":"40","author":"Cristiano","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/jth.15262","article-title":"COVID-19 patients often show high-titer non-platelet-activating anti-PF4\/heparin IgG antibodies","volume":"19","author":"Brodard","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/ijlh.13582","article-title":"The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19","volume":"43","author":"Favaloro","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100980","DOI":"10.1016\/j.nmni.2022.100980","article-title":"Potential association between bacterial infections and ischemic stroke based on fifty case-control studies: A systematic review and meta-analysis","volume":"47","author":"Keikha","year":"2022","journal-title":"New Microbes New Infect."},{"key":"ref_81","first-page":"3","article-title":"Association between bacterial infection and peripheral vascular disease: A review","volume":"25","author":"Ciecierski","year":"2016","journal-title":"Int. J. Angiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fneur.2019.00469","article-title":"Cross-reactivity as a mechanism linking infections to stroke","volume":"10","author":"Lucchese","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","article-title":"Bacterial induction of autoantibodies to \u03b22-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome","volume":"109","author":"Blank","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"Piette","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11926-018-0773-x","article-title":"Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)","volume":"20","author":"Cervera","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e109622","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"Cham","year":"2022","journal-title":"EMBO J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e68563","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00018-022-04329-8","article-title":"Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming","volume":"79","author":"Umar","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41590-021-00962-w","article-title":"SARS-CoV-2 takes its Toll","volume":"22","author":"Sariol","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10565-021-09693-y","article-title":"SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: Endotoxin contamination and lack of protein glycosylation as possible confounders","volume":"38","author":"Cinquegrani","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ouyang, W., Xie, T., Fang, H., Gao, C., Stantchev, T., Clouse, K.A., Yuan, K., Ju, T., and Frucht, D.M. (2021). Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.05.26.445843"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kayesh, M.E.H., Kohara, M., and Tsukiyama-Kohara, K. (2021). An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Viruses, 13.","DOI":"10.3390\/v13112302"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bortolotti, D., Gentili, V., Rizzo, S., Schiuma, G., Beltrami, S., Strazzabosco, G., Fernandez, M., Caccuri, F., Caruso, A., and Rizzo, R. (2021). TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091820"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"21838","DOI":"10.18632\/aging.203560","article-title":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3","volume":"13","author":"Tripathi","year":"2021","journal-title":"Aging"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","article-title":"SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways","volume":"93","author":"Han","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e150542","DOI":"10.1172\/jci.insight.150542","article-title":"SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7\/8","volume":"6","author":"Salvi","year":"2021","journal-title":"JCI Insight"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Severa, M., Diotti, R.A., Etna, M.P., Rizzo, F., Fiore, S., Ricci, D., Iannetta, M., Sinigaglia, A., Lodi, A., and Mancini, N. (2021). Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog., 17.","DOI":"10.1101\/2021.04.17.440278"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fimmu.2020.01021","article-title":"Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e107826","DOI":"10.15252\/embj.2021107826","article-title":"SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation","volume":"40","author":"Thorne","year":"2021","journal-title":"EMBO J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"700926","DOI":"10.3389\/fimmu.2021.700926","article-title":"RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses","volume":"12","author":"Kouwaki","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1038\/s41598-021-92940-3","article-title":"The RNA sensor MDA5 detects SARS-CoV-2 infection","volume":"11","author":"Sampaio","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"102295","DOI":"10.1016\/j.isci.2021.102295","article-title":"SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway","volume":"24","author":"Campbell","year":"2021","journal-title":"iScience"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1038\/s41375-021-01332-z","article-title":"An evidence that SARS-Cov-2\/COVID-19 spike protein (SP) damages hematopoietic stem\/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner","volume":"35","author":"Kucia","year":"2021","journal-title":"Leukemia"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/hum.2007.016","article-title":"Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors","volume":"18","author":"Yamaguchi","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/JVI.01926-06","article-title":"Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses","volume":"81","author":"Nemerow","year":"2007","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","article-title":"Adenovirus-triggered innate signalling pathways","volume":"1","author":"Fejer","year":"2011","journal-title":"Eur. J. Microbiol. Immunol. (Bp)"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/JVI.02591-08","article-title":"Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling","volume":"83","author":"Nociari","year":"2009","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fimmu.2018.00124","article-title":"Humoral Responses Elicited by Adenovirus Displaying Epitopes Are Induced Independently of the Infection Process and Shaped by the Toll-Like Receptor\/MyD88 Pathway","volume":"9","author":"Anchim","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Bagheri-Hosseinabadi, Z., Rezazadeh Zarandi, E., Mirabzadeh, M., Amiri, A., and Abbasifard, M. (2022). mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07437-9"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e67569","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"eLife"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e154183","DOI":"10.1172\/jci.insight.154183","article-title":"Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19","volume":"7","author":"Brauns","year":"2022","journal-title":"JCI Insight"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jfma.2021.06.009","article-title":"Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors","volume":"121","author":"Yang","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Parackova, Z., Zentsova, I., Bloomfield, M., Vrabcova, P., Smetanova, J., Klocperk, A., Mese\u017enikov, G., Casas Mendez, L.F., Vymazal, T., and Sediva, A. (2020). Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils\u2019 but Impaired Monocytes\u2019 and Dendritic Cells\u2019 Responsiveness. Cells, 9.","DOI":"10.3390\/cells9102206"},{"key":"ref_120","first-page":"138","article-title":"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes","volume":"14","author":"Dutta","year":"2022","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/bloodadvances.2021005949","article-title":"Inflammasome activation in neutrophils of patients with severe COVID-19","volume":"6","author":"Aymonnier","year":"2022","journal-title":"Blood Adv."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"780900","DOI":"10.3389\/fimmu.2021.780900","article-title":"Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration","volume":"12","author":"Beghini","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Sultan, R.H., Elesawy, B.H., Ali, T.M., Abdallah, M., Assal, H.H., Ahmed, A.E., and Ahmed, O.M. (2022). Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19. Vaccines, 10.","DOI":"10.1101\/2022.04.08.22273322"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"631226","DOI":"10.3389\/fimmu.2021.631226","article-title":"Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: The first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/ijlh.13717","article-title":"New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data","volume":"43","author":"Wang","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41587-021-01037-9","article-title":"Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children","volume":"40","author":"Loske","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.immuni.2022.01.014","article-title":"SARS-CoV-2 infections in children: Understanding diverse outcomes","volume":"55","author":"Brodin","year":"2022","journal-title":"Immunity"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jaci.2021.06.024","article-title":"Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C)","volume":"148","author":"Chou","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e2214985","DOI":"10.1001\/jamanetworkopen.2022.14985","article-title":"Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children","volume":"5","author":"Abuhammour","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOP.0000000000001061","article-title":"Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children","volume":"33","author":"Schulert","year":"2021","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"632890","DOI":"10.3389\/fimmu.2021.632890","article-title":"Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.18632\/oncotarget.14497","article-title":"Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Lin, I.C., Kuo, H.C., Lin, Y.J., Wang, F.S., Wang, L., Huang, S.C., Chien, S.J., Huang, C.F., Wang, C.L., and Yu, H.R. (2012). Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038635"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3345\/kjp.2017.60.7.208","article-title":"Association of Toll-like receptor 2-positive monocytes with coronary artery lesions and treatment nonresponse in Kawasaki disease","volume":"60","author":"Kang","year":"2017","journal-title":"Korean J. Pediatr."},{"key":"ref_137","first-page":"188","article-title":"Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG","volume":"14","author":"Mortazavi","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"849834","DOI":"10.3389\/fgene.2022.849834","article-title":"Exploration of Potential Biomarker Genes and Pathways in Kawasaki Disease: An Integrated in-Silico Approach","volume":"13","author":"Srivastava","year":"2022","journal-title":"Front. Genet."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Ojha","year":"2020","journal-title":"Science"},{"key":"ref_140","first-page":"e930547","article-title":"Identification of Key Genes and Underlying Mechanisms in Acute Kawasaki Disease Based on Bioinformatics Analysis","volume":"27","author":"Gao","year":"2021","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3892\/etm.2015.2710","article-title":"Association between toll-like receptor 6 expression and auxiliary T cells in the peripheral blood of pediatric patients with allergic purpura","volume":"10","author":"Chang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"21879","DOI":"10.1038\/s41598-022-26608-x","article-title":"Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis","volume":"12","author":"Hu","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2249.2010.04297.x","article-title":"Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease","volume":"163","author":"Giordani","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.humimm.2012.03.011","article-title":"Genetic susceptibility to Kawasaki disease: Analysis of pattern recognition receptor genes","volume":"73","author":"Onoyama","year":"2012","journal-title":"Hum. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12098-022-04126-y","article-title":"Inositol-Triphosphate 3-Kinase C and DNA Methylation Involvement in NLRP3 Inflammasome Activation in Kawasaki Disease","volume":"90","author":"Ji","year":"2022","journal-title":"Indian J. Pediatr."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41419-019-2021-3","article-title":"Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1\/RAGE\/cathespin B signaling pathway and NLRP3 inflammasome activation","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCRESAHA.121.320131","article-title":"Deciphering How NLRP3 Incites the Stromal Response in Kawasaki Vasculitis","volume":"129","author":"Christ","year":"2021","journal-title":"Circ. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13000-022-01207-6","article-title":"Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19","volume":"17","author":"Kogan","year":"2022","journal-title":"Diagn. Pathol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.110.002857","article-title":"Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis","volume":"123","author":"Heidecker","year":"2011","journal-title":"Circulation"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e85851","DOI":"10.1172\/jci.insight.85851","article-title":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis","volume":"1","author":"Myers","year":"2016","journal-title":"JCI Insight"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"23208","DOI":"10.1074\/jbc.M109.047464","article-title":"A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy","volume":"285","author":"Gorbea","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1462-5822.2005.00537.x","article-title":"Human cardiac inflammatory responses triggered by coxsackie B Viruses are mainly Toll-like receptor (TLR) 8-dependent","volume":"7","author":"Triantafilou","year":"2005","journal-title":"Cell. Microbiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.0800861","article-title":"Cutting edge: Cardiac myosin activates innate immune responses through TLRs","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/eji.201747222","article-title":"Cardiolipin activates antigen-presenting cells via TLR2-PI3K-PKN1-AKT\/p38-NF-kB signaling to prime antigen-specific na\u00efve T cells in mice","volume":"48","author":"Cho","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"ra95","DOI":"10.1126\/scisignal.aaa6179","article-title":"Dichotomous roles for externalized cardiolipin in extracellular signaling: Promotion of phagocytosis and attenuation of innate immunity","volume":"8","author":"Balasubramanian","year":"2015","journal-title":"Sci. Signal."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"9946439","DOI":"10.1155\/2022\/9946439","article-title":"Extracellular Cardiolipin Modulates Select Immune Functions of Astrocytes in Toll-Like Receptor (TLR) 4-Dependent Manner","volume":"2022","author":"Murray","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"577496","DOI":"10.1016\/j.jneuroim.2021.577496","article-title":"Extracellular cardiolipin modulates microglial phagocytosis and cytokine secretion in a toll-like receptor (TLR) 4-dependent manner","volume":"353","author":"Wenzel","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"key":"ref_159","first-page":"8158","article-title":"Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"101182","DOI":"10.1016\/j.plipres.2022.101182","article-title":"Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome","volume":"87","author":"Pizzuto","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.97.4.1743","article-title":"Cardiolipin is a normal component of human plasma lipoproteins","volume":"97","author":"Deguchi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/femsre\/fuv008","article-title":"Bacterial membrane lipids: Diversity in structures and pathways","volume":"40","author":"Sohlenkamp","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_163","first-page":"1287","article-title":"Bacterial lipid diversity","volume":"1862","author":"Geiger","year":"2017","journal-title":"Biochim. Et Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1139\/o77-183","article-title":"Further studies on the cardiolipin phosphodiesterase of Escherichia coli","volume":"55","author":"Cole","year":"1977","journal-title":"Can. J. Biochem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/jth.14994","article-title":"Antiphospholipid antibodies in patients with COVID-19: A relevant observation?","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11926-021-01041-7","article-title":"The Role of Antiphospholipid Antibodies in COVID-19","volume":"23","author":"Stelzer","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-021-01029-3","article-title":"Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","volume":"23","author":"Foret","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: A critical review of their association with thrombosis","volume":"14","author":"Kelchtermans","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jth.14261","article-title":"Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-\u03b22glycoprotein I antibody detection assays","volume":"16","author":"Chayoua","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Schenkein, H.A., and Thomas, R.R. (2018). Anticardiolipin (aCL) in sera from periodontitis subjects activate Toll-like receptor 4 (TLR4). PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203494"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"957201","DOI":"10.3389\/fimmu.2022.957201","article-title":"Circulating immune-complexes of IgG\/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome","volume":"13","author":"Naranjo","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5551\/jat.34488","article-title":"Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events","volume":"23","author":"Serrano","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.04.021","article-title":"Prevalence of aPhosphatidylserine\/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis","volume":"214","author":"Zhu","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.15785","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jth.12536","article-title":"NF-kB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes","volume":"12","author":"Brandt","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Gladigau, G., Haselmayer, P., Scharrer, I., Munder, M., Prinz, N., Lackner, K., Schild, H., Stein, P., and Radsak, M.P. (2012). A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042176"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1182\/blood-2010-11-316158","article-title":"Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies","volume":"117","author":"Satta","year":"2011","journal-title":"Blood"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0897.2009.00717.x","article-title":"Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4\/MyD88 pathway","volume":"62","author":"Mulla","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.42068","article-title":"Antiphospholipid Antibodies Increase Endometrial Stromal Cell Decidualization, Senescence, and Inflammation via Toll-like Receptor 4, Reactive Oxygen Species, and p38 MAPK Signaling","volume":"74","author":"Tong","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.imbio.2008.12.003","article-title":"TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells","volume":"214","author":"Hurst","year":"2009","journal-title":"Immunobiology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood-2011-01-330639","article-title":"Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells","volume":"118","author":"Prinz","year":"2011","journal-title":"Blood"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.imbio.2009.03.002","article-title":"Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8","volume":"215","author":"Hurst","year":"2010","journal-title":"Immunobiology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/molehr\/gaw027","article-title":"Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8","volume":"22","author":"Gysler","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaut.2018.12.003","article-title":"Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammation","volume":"98","author":"Mulla","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Mulla, M.J., Salmon, J.E., Chamley, L.W., Brosens, J.J., Boeras, C.M., Kavathas, P.B., and Abrahams, V.M. (2013). A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1\u03b2 production by human first trimester trophoblast. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065237"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"\u03b22-glycoprotein I, lipopolysaccharide and endothelial TLR4: Three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.1000526","article-title":"TLR2 Is One of the Endothelial Receptors for \u03b22-Glycoprotein I","volume":"185","author":"Alard","year":"2010","journal-title":"J. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/art.38785","article-title":"Role of Toll-like Receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","volume":"66","author":"Benhamou","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2004.07.007","article-title":"Innate immunity in the antiphospholipid syndrome: Role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies","volume":"3","author":"Meroni","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203314536479","article-title":"Toll-like receptor 4 and \u03b22 glycoprotein I interaction on endothelial cells","volume":"23","author":"Borghi","year":"2014","journal-title":"Lupus"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/0961203308095140","article-title":"Toll-like receptors: Another player in the pathogenesis of the anti-phospholipid syndrome","volume":"17","author":"Raschi","year":"2008","journal-title":"Lupus"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.thromres.2013.09.039","article-title":"Anti-\u03b22GPI\/\u03b22GPI stimulates activation of THP-1 cells through TLR4\/MD-2\/MyD88 and NF-\u03baB signaling pathways","volume":"132","author":"Zhou","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_194","first-page":"4353","article-title":"Role of TLR-4 in anti-\u03b22-glycoprotein I-induced activation of peritoneal macrophages and vascular endothelial cells in mice","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1074\/jbc.RA120.012741","article-title":"Thrombin-derived C-terminal fragments aggregate and scavenge bacteria and their proinflammatory products","volume":"295","author":"Petrlova","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.intimp.2013.06.034","article-title":"Neutrophil cell surface receptors and their intracellular signal transduction pathways","volume":"17","author":"Futosi","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.3390\/molecules20069745","article-title":"Molecular Interactions of \u03b2-(1\u21923)-Glucans with Their Receptors","volume":"20","author":"Legentil","year":"2015","journal-title":"Molecules"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0968051907080024","article-title":"Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: Implications for the monocyte activation test","volume":"13","author":"Kikkert","year":"2007","journal-title":"J. Endotoxin. Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acsptsci.1c00219","article-title":"Experimental Model of Pulmonary Inflammation Induced by SARS-CoV-2 Spike Protein and Endotoxin","volume":"5","author":"Puthia","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jmcb\/mjaa067","article-title":"SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity","volume":"12","author":"Petruk","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Tumpara, S., Gr\u00fcnding, A.R., Sivaraman, K., Wrenger, S., Olejnicka, B., Welte, T., Wurm, M.J., Pino, P., Kiseljak, D., and Wurm, F.M. (2021). Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by \u03b1-1 Antitrypsin. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157941"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Loke, M.F., Yadav, I., Lim, T.K., van der Maarel, J.R.C., Sham, L.T., and Chow, V.T. (2022). SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation by Streptococcus pneumoniae and Staphylococcus aureus. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063291"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41421-022-00453-8","article-title":"Surface translocation of ACE2 and TMPRSS2 upon TLR4\/7\/8 activation is required for SARS-CoV-2 infection in circulating monocytes","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Discov."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Mairpady Shambat, S., G\u00f3mez-Mejia, A., Schweizer, T.A., Huemer, M., Chang, C.C., Acevedo, C., Bergada-Pijuan, J., Vulin, C., Hofmaenner, D.A., and Scheier, T.C. (2022). Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010176"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"121393","DOI":"10.1016\/j.biomaterials.2022.121393","article-title":"DAMPs\/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists","volume":"283","author":"Naqvi","year":"2022","journal-title":"Biomaterials"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1022.e1","DOI":"10.1016\/j.cmi.2022.01.021","article-title":"Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations","volume":"28","author":"Boumasmoud","year":"2022","journal-title":"Clin. Microbiol Infect."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"e140329","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.jtauto.2022.100154","article-title":"SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases","volume":"5","author":"Larionova","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2020.11.031","article-title":"Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week","volume":"77","author":"Kawakami","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"ofab279","DOI":"10.1093\/ofid\/ofab279","article-title":"Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children","volume":"8","author":"Kumar","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_212","first-page":"242","article-title":"POS0072 comprehensive immune profiling of 20 children with multisystem inflammatory syndrome","volume":"80","author":"Avramovic","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"8442855","DOI":"10.1155\/2022\/8442855","article-title":"Unusual Presentation of Multisystemic Inflammatory Syndrome","volume":"2022","author":"Ebrahim","year":"2022","journal-title":"Case Rep. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0049-0172(95)80027-1","article-title":"Antineutrophil cytoplasmic antibodies: Major autoantigens, pathophysiology, and disease associations","volume":"25","author":"Schultz","year":"1995","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"152047","DOI":"10.1016\/j.semarthrit.2022.152047","article-title":"COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis","volume":"55","author":"Batu","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12969-022-00727-1","article-title":"A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature","volume":"20","author":"Bryant","year":"2022","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11239-021-02470-y","article-title":"Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: Cause of disease or epiphenomenon?","volume":"52","author":"Pavoni","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11926-013-0343-1","article-title":"Clinical significance of IgA anti-cardiolipin and IgA anti-\u03b22glycoprotein I antibodies","volume":"15","author":"Andreoli","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"110","DOI":"10.11604\/pamj.2022.42.110.33020","article-title":"Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia","volume":"42","author":"Bnina","year":"2022","journal-title":"Pan Afr. Med. J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0961203310361492","article-title":"The dual role of innate immunity in the antiphospholipid syndrome","volume":"19","author":"Rauch","year":"2010","journal-title":"Lupus"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.4049\/jimmunol.0802884","article-title":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4\/MyD88 and the cGMP-dependent protein kinase pathway","volume":"182","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13317-019-0113-9","article-title":"Anti-\u03b22-glycoprotein I and anti-phosphatidylserine\/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells","volume":"10","author":"Domenis","year":"2019","journal-title":"Auto Immun. Highlights"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"42494","DOI":"10.1074\/jbc.M111.230383","article-title":"Interaction of \u03b22-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages","volume":"286","author":"Laplante","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e022482","DOI":"10.1161\/JAHA.121.022482","article-title":"Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke","volume":"10","author":"Toppila","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2958.2007.05974.x","article-title":"The antibacterial activity of peptides derived from human \u03b22 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes","volume":"67","author":"Nilsson","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"\u03b22-glycoprotein I: A novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/TH11-05-0333","article-title":"Evolutionary conservation of the lipopolysaccharide binding site of \u03b2\u2082-glycoprotein I","volume":"106","author":"Marquart","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity\u2014Friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"102662","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R., Churchill, E., and Oliverio, S. (2023). T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021335"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/08916934.2014.961061","article-title":"Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB\/c and C57BL\/6 mice","volume":"48","author":"Muhandes","year":"2015","journal-title":"Autoimmunity"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0961203311429816","article-title":"Vaccine model of antiphospholipid syndrome induced by tetanus vaccine","volume":"21","year":"2012","journal-title":"Lupus"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin. Immun."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: Implications for autoimmune diseases","volume":"11","author":"Vojdani","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Passariello, M., Vetrei, C., Amato, F., and De Lorenzo, C. (2021). Interactions of spike-RBD of SARS-CoV-2 and Platelet Factor 4: New insights in the etiopathogenesis of thrombosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168562"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0041-1731068","article-title":"Thromboses and hemostasis disorders associated with COVID-19: The possible causal role of cross-reactivity and immunological imprinting","volume":"8","author":"Kanduc","year":"2021","journal-title":"Glob. Med. Genet."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"119333","DOI":"10.1016\/j.biomaterials.2019.119333","article-title":"Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation","volume":"218","author":"Casey","year":"2019","journal-title":"Biomaterials"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jth.15362","article-title":"Evaluation of laboratory assays for anti-Platelet Factor 4 antibodies after ChAdOx1 nCOV-19 vaccination","volume":"19","author":"Platton","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination","volume":"19","author":"Horvei","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162\u03b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Terpos, E., Politou, M., Ntanasis-Stathopoulos, I., Karalis, V., Merkouri, E., Fotiou, D., Gavriatopoulou, M., Malandrakis, P., Kastritis, E., and Trougakos, I.P. (2021). High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events. Vaccines, 9.","DOI":"10.3390\/vaccines9070712"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ijlh.13629","article-title":"Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia","volume":"43","author":"Favaloro","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Thurm, C., Reinhold, A., Borucki, K., Kahlfuss, S., Feist, E., Schreiber, J., Reinhold, D., and Schraven, B. (2022). Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome. Vaccines, 10.","DOI":"10.3390\/vaccines10020333"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"930074","DOI":"10.3389\/fimmu.2022.930074","article-title":"Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers","volume":"15","author":"Borghi","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Krashias, G., Pafiti, A., Deeba, E., Christodoulou, C., Pantzaris, M., and Lambrianides, A. (2022). SARS CoV- 2 vaccination induces antibodies against cardiolipin. BMC Res. Notes, 15.","DOI":"10.1186\/s13104-022-06180-3"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/rheumatology\/keac400","article-title":"COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary antiphospholipid syndrome: A prospective study","volume":"62","author":"Pan","year":"2022","journal-title":"Rheumatology"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/09612033221102073","article-title":"Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome","volume":"31","author":"Signorelli","year":"2022","journal-title":"Lupus"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., Haddad, A., Elias, M., Zisman, D., and Naffaa, M.E. (2021). Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA\/DNA SARS-CoV-2 Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9050435"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1128\/JVI.02562-08","article-title":"Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells","volume":"83","author":"Jonsson","year":"2009","journal-title":"J. Virol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/hum.2007.0051","article-title":"Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia","volume":"18","author":"Hofherr","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/hum.2015.154","article-title":"Pseudotyping serotype 5 adenovirus with the fiber from other serotypes uncovers a key role of the fiber protein in adenovirus 5-induced thrombocytopenia","volume":"27","author":"Raddi","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4049\/jimmunol.175.3.1498","article-title":"Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock","volume":"175","author":"Szalay","year":"2005","journal-title":"J. Immunol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"118832","DOI":"10.1016\/j.lfs.2020.118832","article-title":"Enhanced expression of coxsackievirus and adenovirus receptor in lipopolysaccharide-induced inflammatory macrophages is through TRIF-dependent innate immunity pathway","volume":"265","author":"Lin","year":"2021","journal-title":"Life Sci."},{"key":"ref_258","first-page":"189","article-title":"Modulation of the coagulation system during severe streptococcal disease","volume":"368","author":"Shannon","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fmed.2020.00543","article-title":"Impact of Von Willebrand Factor on bacterial pathogenesis","volume":"7","author":"Steinert","year":"2020","journal-title":"Front. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/mmi.13604","article-title":"Collagen-like proteins of pathogenic streptococci","volume":"103","author":"Lukomski","year":"2017","journal-title":"Mol. Microbiol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"e0116721","DOI":"10.1128\/mBio.01167-21","article-title":"vhp is a fibrinogen-binding protein related to vWbp in Staphylococcus aureus","volume":"12","author":"Thomas","year":"2021","journal-title":"mBio"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"Blauwet","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions","volume":"18","author":"Ammirati","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.molimm.2003.11.023","article-title":"T cell mimicry in inflammatory heart disease","volume":"40","author":"Cunningham","year":"2004","journal-title":"Mol. Immunol."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Wiemken, T.L., McGrath, L.J., Andersen, K.M., Khan, F., Malhotra, D., Alfred, T., Nguyen, J.L., Puzniak, L., Thoburn, E., and Jodar, L. (2022). COVID-19 severity and risk of subsequent cardiovascular events. Clin. Infect. Dis., ciac661.","DOI":"10.1093\/cid\/ciac661"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/acscentsci.1c00361","article-title":"An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory","volume":"7","author":"Haabeth","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jconrel.2022.05.023","article-title":"Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine","volume":"347","author":"Atalis","year":"2022","journal-title":"J. Control Release"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acs.molpharmaceut.0c01256","article-title":"Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity","volume":"18","author":"Bakkari","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/sji.12188","article-title":"The role of Toll-like receptors and vitamin D in diabetes mellitus type 1--a review","volume":"80","author":"Adamczak","year":"2014","journal-title":"Scand J. Immunol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Salazar, J., Angarita, L., Morillo, V., Navarro, C., Mart\u00ednez, M.S., Chac\u00edn, M., Torres, W., Rajotia, A., Rojas, M., and Cano, C. (2020). Microbiota and Diabetes Mellitus: Role of Lipid Mediators. Nutrients., 12.","DOI":"10.3390\/nu12103039"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1007\/s12010-022-03979-5","article-title":"Human Fungal Infection, Immune Response, and Clinical Challenge-a Perspective During COVID-19 Pandemic","volume":"194","author":"Naveen","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1967699","DOI":"10.1080\/20002297.2021.1967699","article-title":"Mycotic infections\u2014Mucormycosis and oral candidiasis associated with Covid-19: A significant and challenging association","volume":"13","author":"Nambiar","year":"2021","journal-title":"J. Oral Microbiol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"35237","DOI":"10.1074\/jbc.R114.619304","article-title":"Complexity of danger: The diverse nature of damage-associated molecular patterns","volume":"289","author":"Schaefer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","article-title":"Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets","volume":"89 Pt B","author":"Kumar","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacbts.2020.03.015","article-title":"Innate Immune Receptors, Key Actors in Cardiovascular Diseases","volume":"5","author":"Prieto","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"796066","DOI":"10.3389\/fcell.2022.796066","article-title":"Role of Mitochondrial Nucleic Acid Sensing Pathways in Health and Patho-Physiology","volume":"10","author":"Chowdhury","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijid.2021.10.001","article-title":"COVID-19 and antimicrobial stewardship: Lessons learned, best practices, and future implications","volume":"113","author":"Pierce","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhin.2022.08.005","article-title":"The impact of COVID-19 on antimicrobial stewardship programme implementation in hospitals\u2014An exploration informed by the Consolidated Framework for Implementation Research","volume":"129","author":"Hashad","year":"2022","journal-title":"J. Hosp. Infect."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","article-title":"Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: A retrospective cohort study in light of antibiotic stewardship","volume":"40","author":"Rothe","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1016\/j.vaccine.2020.06.047","article-title":"Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality","volume":"38","author":"Thindwa","year":"2020","journal-title":"Vaccine"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"e02347-20","DOI":"10.1128\/mBio.02347-20","article-title":"Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV","volume":"12","author":"Nunes","year":"2021","journal-title":"mBio"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.chest.2020.05.580","article-title":"Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing","volume":"158","author":"Jehi","year":"2020","journal-title":"Chest"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41598-021-83641-y","article-title":"Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations","volume":"11","author":"Pawlowski","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Noale, M., Trevisan, C., Maggi, S., Incalzi, R.A., Pedone, C., Di Bari, M., Adorni, F., Jesuthasan, N., Sojic, A., and Galli, M. (2020). The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey. Vaccines, 8.","DOI":"10.3390\/vaccines8030471"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jiab128","article-title":"Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract","volume":"225","author":"Lewnard","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"e10910","DOI":"10.7717\/peerj.10910","article-title":"Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study","volume":"9","author":"Sumbul","year":"2021","journal-title":"PeerJ"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"2000076","DOI":"10.1002\/bies.202000076","article-title":"Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?","volume":"42","year":"2020","journal-title":"BioEssays"},{"key":"ref_291","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R. (2020). Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death. Vaccines, 8.","DOI":"10.20944\/preprints202007.0141.v2"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"106674","DOI":"10.1016\/j.rmed.2021.106674","article-title":"A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP\/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement","volume":"190","author":"Blasi","year":"2021","journal-title":"Respir. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/aas.14167","article-title":"Heterogenous treatment effects of dexamethasone 12 mg vs. 6 mg in patients with COVID-19 and severe hypoxaemia\u2014Post hoc exploratory analyses of the COVID STEROID 2 trial","volume":"67","author":"Granholm","year":"2022","journal-title":"Acta Anaesthesiol. Scand."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/3001\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:20Z","timestamp":1760120600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/3001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":293,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24033001"],"URL":"https:\/\/doi.org\/10.3390\/ijms24033001","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}